Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment
OK Siddiqi, FL Ruberg - Trends in cardiovascular medicine, 2018 - Elsevier
The amyloidoses are a group of systemic diseases characterized by organ deposition of
misfolded protein fragments of diverse origins. The natural history of the disease …
misfolded protein fragments of diverse origins. The natural history of the disease …
Pathophysiology and treatment of cardiac amyloidosis
MA Gertz, A Dispenzieri, T Sher - Nature Reviews Cardiology, 2015 - nature.com
Amyloid cardiomyopathy should be suspected in any patient who presents with heart failure
and preserved ejection fraction. In patients with echocardiographic evidence of ventricular …
and preserved ejection fraction. In patients with echocardiographic evidence of ventricular …
Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association
Transthyretin amyloid cardiomyopathy (ATTR-CM) results in a restrictive cardiomyopathy
caused by extracellular deposition of transthyretin, normally involved in the transportation of …
caused by extracellular deposition of transthyretin, normally involved in the transportation of …
[HTML][HTML] Cardiac amyloidosis: the need for early diagnosis
M Oerlemans, KHG Rutten, MC Minnema… - Netherlands Heart …, 2019 - Springer
Amyloidosis is a collection of systemic diseases characterised by misfolding of previously
soluble precursor proteins that become infiltrative depositions, thereby disrupting normal …
soluble precursor proteins that become infiltrative depositions, thereby disrupting normal …
Epidemiology and clinical manifestations of cardiac amyloidosis
F Bajwa, R O'Connor, K Ananthasubramaniam - Heart failure reviews, 2022 - Springer
Cardiac amyloidosis, once considered a rare disease, has garnered significant attention
over the last few years due to three key reasons: first, increased recognition of this disease …
over the last few years due to three key reasons: first, increased recognition of this disease …
Cardiac amyloidosis: overlooked, underappreciated, and treatable
Cardiac amyloidosis (CA) is an infiltrative and restrictive cardiomyopathy that leads to heart
failure, reduced quality of life, and death. The disease has two main subtypes, transthyretin …
failure, reduced quality of life, and death. The disease has two main subtypes, transthyretin …
Cardiac amyloidosis: An underdiagnosed/underappreciated disease
AS Manolis, AA Manolis, TA Manolis… - European Journal of …, 2019 - Elsevier
Cardiac amyloidosis or amyloid cardiomyopathy (ACM), commonly resulting from
extracellular deposition of amyloid fibrils consisted of misfolded immunoglobulin light chain …
extracellular deposition of amyloid fibrils consisted of misfolded immunoglobulin light chain …
Ventricular arrhythmias in cardiac amyloidosis: a review of current literature
S Khanna, P Lo, K Cho… - Clinical Medicine Insights …, 2020 - journals.sagepub.com
Cardiac Amyloidosis is an infiltrative cardiomyopathy which occurs secondary to deposition
of mis-folded protein in the myocardium, with the two most common subtypes being AL …
of mis-folded protein in the myocardium, with the two most common subtypes being AL …
[PDF][PDF] Cardiac amyloidosis: an update on diagnosis and treatment
JP Donnelly, M Hanna - Cleve Clin J Med, 2017 - cdn.mdedge.com
Cardiac amyloidosis (CA), once thought to be a rare disease, is increasingly recognized due
to enhanced clinical awareness and better diagnostic imaging. CA is becoming of …
to enhanced clinical awareness and better diagnostic imaging. CA is becoming of …
Cardiac amyloidosis: diagnosis and treatment strategies
Cardiac amyloidosis in the United States is most often due to myocardial infiltration by
immunoglobulin protein, such as in AL amyloidosis, or by the protein transthyretin, such as …
immunoglobulin protein, such as in AL amyloidosis, or by the protein transthyretin, such as …
相关搜索
- diagnosis and treatment cardiac amyloidosis
- update on pathophysiology cardiac amyloidosis
- underappreciated disease cardiac amyloidosis
- heart association cardiac amyloidosis
- position statement cardiac amyloidosis
- management of patients cardiac amyloidosis
- clinical manifestations cardiac amyloidosis
- update on diagnosis cardiac amyloidosis
- evolving diagnosis cardiac amyloidosis
- diagnosis and management cardiac amyloidosis
- early diagnosis cardiac amyloidosis
- scientific statement cardiac amyloidosis
- evaluation and management cardiac amyloidosis